Korean J Gastroenterol.  2015 Apr;65(4):197-198. 10.4166/kjg.2015.65.4.197.

Dabigatran vs. Warfarin; Is It Time to Change?

• Kim JS
• Kim BW

• KMID: 2373209
• DOI: http://doi.org/10.4166/kjg.2015.65.4.197

Abstract

No abstract available.

Reference

References

1. Mega JL, Simon T. Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments. Lancet. 2015. doi: 10.1016/S0140-6736(15)60243-4. [Epub ahead of print].

2. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014; 383:955–962.

3. Sherid M, Sifuentes H, Sulaiman S, et al. Gastrointestinal bleeding with dabigatran, a comparative study with warfarin: a multicenter experiences. Korean J Gastroenterol. 2015; 65:205–214.

4. Eikelboom JW, Wallentin L, Connolly SJ, et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation. 2011; 123:2363–2372.

5. Desai J, Granger CB, Weitz JI, Aisenberg J. Novel oral anticoagulants in gastroenterology practice. Gastrointest Endosc. 2013; 78:227–239.